More reduction in the RFP + tumor cell number was detected in CF17-GFP-NPC-treated mouse brains, compared to CF17-GFP alone-treated brains at both MOI = 0.3 and MOI = 3, although the difference at MOI = 0.3 did not reach statistical significance ( Figure 3 B).
← all excerpts
Targeting glioblastoma using oncolytic viruses delivered by human pluripotent stem cell-derived neural progenitor cells.
1
—
—